Nufarm Limited (NUFMF) Q2 2025 Earnings Call Transcript

Nufarm Limited (NUFMF) reported a mixed first half of 2025, with underlying EBIT of $103 million, a 34% increase in Crop Protection EBIT offset by challenges in its omega-3 business, leading to a $28 million inventory write-down. The company is initiating a strategic review of its Seed Technologies, including exploring outside capital, to accelerate growth in hybrid canola, sorghum, sunflower seeds, omega-3, and bioenergy platforms. Nufarm is targeting $50 million in annualized cost savings and a 25-day reduction in inventory days by the end of fiscal year 2025 to improve profitability and deleverage, but uncertainties remain in the second half due to volatile fish oil prices and tariffs.

Analysis

Nufarm Limited's first-half 2025 results presented a bifurcated performance, with its Crop Protection segment demonstrating robust recovery while the Seed Technologies division faced significant headwinds, primarily from its omega-3 platform. Underlying EBIT reached $103 million, supported by a 34% year-on-year increase in Crop Protection EBIT, driven by volume growth across all regions and margin normalization, particularly in APAC (EBIT +34%) and Europe (EBIT nearly doubled). However, this was offset by challenges in Seed Technologies, where underlying EBIT fell to $15.9 million due to a $28 million inventory write-down in the omega-3 business (Aquaterra) caused by a sharp decline in fish oil prices; consequently, Nufarm will not achieve its $100 million omega-3 revenue target for FY25 and plans to halve planted acres in 2025. In response to these challenges and to unlock value, Nufarm has initiated a strategic review of its Seed Technologies, engaging UBS to explore capital structure options, including outside equity, with an update expected by late calendar year 2025. The company's leverage increased to 4.5 times underlying EBITDA, prompting the suspension of the interim dividend, but management outlined a deleveraging plan targeting 1.5-2.0 times by FY26 through actions including $50 million in annualized cost savings, a 25-day inventory reduction by end-FY25, and reduced CapEx (expected circa $200 million in FY26). Despite current omega-3 market volatility, Nufarm sees long-term potential in its Seed Technologies, particularly in bioenergy (carinata) with a planned 3x planting expansion, and its established hybrid seeds. The second-half outlook remains cautious due to ongoing fish oil price weakness, potential U.S. tariff impacts, and dry conditions in Australia, though management anticipates improved volumes in North America.

Key Decisions for Investors

• Investors should closely monitor the progress and outcomes of the Seed Technologies strategic review, as any transaction or restructuring could significantly impact Nufarm's valuation and strategic focus, particularly for the high-potential bioenergy and challenged omega-3 platforms.
• It is crucial to evaluate the company's ability to execute its deleveraging plan, including achieving targeted cost savings of $50 million and inventory reductions, as success is critical for restoring balance sheet health to the target 1.5-2.0x leverage range and the potential resumption of dividends.
• Consider the recovery trajectory of the omega-3 business, factoring in external fish oil market dynamics and Nufarm's internal cost-reduction initiatives, given this segment's material impact on current earnings, working capital, and the $28 million inventory write-down.
• Investors should weigh the near-term headwinds for Crop Protection, such as U.S. tariff uncertainties and Australian weather conditions, against the backdrop of low channel inventories and stabilizing active ingredient prices, which will influence second-half performance and regional profitability.